Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes

Table 12 Comparison of colorectal cancer outcomes with the European Society of Coloproctology international audit and CovidSurg collaboration data

	Right colon			Left colon			Rectal
%	ESCP	CSURG	Ours	ESCP	CSURG	Ours	ESCP	CSURG	Ours
N	2225	724	15	989	367	13	2579	935	20
MIS	54.4	54.7	53.3	53.6	62.9	53.8	54.2	57.8	90
Open	36.5	41	33.3	36.8	29.7	38.4	35.8	38.0	5
Conv	9.1	4.3	13.3	9.6	7.4	7.7	10	4.2	5
ANAST	98.6	93.5	100	93.3	86.1	76.9	42.8	37.4	27.3
ANAST +DEF	0.3	1.4	0	1.8	5.7	0	33.5	35.4	45.451
End stoma	1.1	5.1	0	4.9	8.2	23.1	23.7	27.2	27.31
Leak	6.5	3.6	0	7.5	4.1	0	9.2	6.5	5; 12.52
Death	1.7	1.2	0	0.7	1.6	7.7	0.8	2.0	0

¹Excluded abdominoperineal resection patients.

²Considering only anastomosed patients. Data shown as % except first file.

1 patient with total colectomy in included in left colon (sigmoid cancer). MIS: Minimally invasive surgery; Conv: MIS-Conversion; ANAST: Anastomoses; DEF: Defunctioning stoma; ESCP: European society of coloproctology; CSURG: CovidSurg cancer study on colorectal surgery.